Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 197,000 | N/A | N/A | N/A |
| Marketable Securities | N/A | 167,000 | N/A | N/A | N/A |
| Receivables | N/A | 718,000 | N/A | N/A | N/A |
| Inventories | N/A | 565,000 | N/A | N/A | N/A |
| TOTAL | $N/A | $1,647,000 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 166,000 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 2,000 | 0 | 0 | 0 |
| TOTAL | $N/A | $168,000 | $N/A | $N/A | $N/A |
| Total Assets | $3,383,530 | $3,434,000 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 115,000 | 0 | 0 | 0 |
| Other current liabilities | N/A | 494,000 | N/A | N/A | N/A |
| TOTAL | $N/A | $713,000 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 103,000 | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 0 | 65,000 | 0 | 0 | 0 |
| TOTAL | $N/A | $329,000 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,049,250 | $1,042,000 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | N/A | 84,000 | N/A | N/A | N/A |
| Retained earnings | N/A | 1,955,000 | N/A | N/A | N/A |
| Other shareholders' equity | 2,334,270 | 48,000 | 0 | 0 | 0 |
| TOTAL | $2,334,270 | $2,392,000 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $3,383,520 | $3,434,000 | $0 | $0 | $0 |